CINCINNATI—Litsa Kranias, PhD, distinguished professor and chair of pharmacology and cell biophysics at the University of Cincinnati College of Medicine, has been designated a 2009 American Heart Association (AHA) Distinguished Scientist for her contributions to cardiovascular and stroke research.
Kranias is one of fewer than 50 researchers and scientists in the United States and one of only four women to be honored with the prestigious award.
She will be recognized at the American Heart Association Scientific Sessions 2009 Nov. 14-18 in Orlando, Fla.
“This is a tremendous honor,” says Kranias, who also holds the Hanna Endowed Chair in Cardiology. “It shows the high respect of my colleagues for my work and my contributions, and that is a great reward for all of the time and effort I’ve put into my research projects. This is an honor that I will cherish for the rest of my life.”
Kranias has been the director of cardiovascular biology since 1995 and co-director of the Cardiovascular Center of Excellence at UC since 2007. She leads the multidisciplinary research effort to define the defects in calcium-regulated cellular mechanisms associated with heart failure and identify new therapies.
Kranias serves on the research committee of the AHA, on the executive committee of the International Society of Heart Research (ISHR) and as treasurer of the North American Section of the ISHR.
She is also a founding fellow of the ISHR and is involved in a number of other organizations that promote the widespread distribution of heart information and research.
“Litsa has distinguished herself with many notable contributions and groundbreaking discoveries in the field of molecular cardiology. Most importantly, she has worked closely with clinicians to translate these findings from the laboratory to actual application in patients, strengthening translational medicine at the University of Cincinnati,” says David Stern, MD, dean of the College of Medicine and vice president for health affairs at UC.
Kranias has been a faculty member of the UC College of Medicine since 1978. In 2008 she received the Daniel Drake Medal, the college’s highest honor.
She has distinguished herself internationally as a molecular cardiac researcher and has received continuous funding by the National Institutes of Health (NIH). She has also collaborated with many physicians, nationally and internationally, on research efforts, and has assumed many national and international leadership roles.
“I have worked in the heart field all my life, and this is the ultimate honor,” says Kranias.